Periodic Reporting for period 2 - RBDCOV (RBD Dimer recombinant protein vaccine against SARSCoV2)

RBDCOV aims to test the efficacy, tolerability, and safety of the HIPRA vaccine for COVID-19. HIPRA's vaccine is an adjuvanted recombinant protein vaccine, based on a receptor binding domain (RBD) fusion heterodimer against SARS-CoV-2. RBDCOV aims to generate robust data to...